Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Two potent therapeutic strategies based on the GLP-1 system have been developed for the treatment of type 2 diabetes [1]
Key Safety Monitoring: Regular assessment for pancreatitis symptoms (severe abdominal pain) Monitoring for gallbladder disease in patients with risk factors Thyroid surveillance with annual TSH and symptom assessment Blood glucose monitoring if concurrent diabetes medications are used Future Directions and Research Emerging research on GLP-1-estrogen conjugates shows promise for even more targeted therapy in menopausal women
88 It is important to note that both groups were resistant to other reproductive treatments, and weight loss was observed in both groups, indicating the potential existence of other mechanisms exerted by GLP-1RAs that improve pregnancy outcomes other than weight loss
68 , 6672 (2018) Funding Open access funding provided by the Scientific and Technological Research Council of Trkiye (TBTAK)
US$ 22.88
US$ 27.14
US$ 25.82
US$ 28.40
US$ 28.10
US$ 23.49
US$ 24.44
